Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MADS MEJNERTSEN / REG. BESLAGSMED ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   2.1% 2.1% 2.1% 2.1% 2.1% 2.1% 2.1% 2.1%   Bankruptcy risk   4.3% 7.0% 6.5% 7.0% 12.5% 7.4% 17.2% 17.1%   Credit score (0-100)   49 34 35 34 18 33 9 10   Credit rating   BBB BBB BBB BBB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   1,714 0 0 0 0 0 0 0   Gross profit   1,103 964 841 945 1,169 1,039 0.0 0.0   EBITDA   130 105 8.9 48.1 244 -42.5 0.0 0.0   EBIT   54.8 20.9 -77.0 -39.9 160 -81.8 0.0 0.0   Pre-tax profit (PTP)   34.8 3.6 -93.6 -61.0 131.3 -93.5 0.0 0.0   Net earnings   20.8 -1.7 -76.8 -51.6 88.4 -84.2 0.0 0.0   Pre-tax profit without non-rec. items   34.8 3.6 -93.6 -61.0 131 -93.5 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   370 285 217 129 45.0 5.7 0.0 0.0   Shareholders equity total   214 212 135 83.7 172 87.9 -37.1 -37.1   Interest-bearing liabilities   245 0.0 133 56.2 0.0 58.1 37.1 37.1   Balance sheet total (assets)   797 706 541 433 566 411 0.0 0.0   Net Debt   239 -114 126 49.7 -93.0 51.6 37.1 37.1     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   1,714 0 0 0 0 0 0 0   Net sales growth   -15.0% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,103 964 841 945 1,169 1,039 0.0 0.0   Gross profit growth   -22.4% -12.6% -12.7% 12.4% 23.7% -11.2% -100.0% 0.0%   Employees   2 2 2 2 2 3 0 0   Employee growth %   -33.3% 0.0% 0.0% 0.0% 0.0% 50.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   797 706 541 433 566 411 0 0   Balance sheet change%   36.5% -11.4% -23.3% -20.1% 30.9% -27.5% -100.0% 0.0%   Added value   130.2 105.3 8.9 48.1 247.8 -42.5 0.0 0.0   Added value %   7.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   148 -169 -154 -176 -169 -79 -6 0   Net sales trend   -3.0 -4.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 -2.0 1.0 -1.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   7.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   3.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   5.0% 2.2% -9.2% -4.2% 13.7% -7.9% 0.0% 0.0%   Net Earnings %   1.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   5.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   2.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   7.9% 2.8% -12.4% -8.2% 32.0% -16.8% 0.0% 0.0%   ROI %   14.6% 5.4% -27.2% -17.3% 96.6% -51.4% 0.0% 0.0%   ROE %   10.2% -0.8% -44.2% -47.2% 69.1% -64.8% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   26.8% 30.1% 25.0% 19.4% 30.4% 21.4% -100.0% -100.0%   Relative indebtedness %   30.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   30.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   183.4% -108.2% 1,416.8% 103.1% -38.1% -121.4% 0.0% 0.0%   Gearing %   114.7% 0.0% 98.2% 67.2% 0.0% 66.1% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   16.3% 14.1% 25.0% 22.3% 101.4% 40.2% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.6 0.7 0.6 0.3 0.8 0.7 0.0 0.0   Current Ratio   0.8 1.0 0.9 0.9 1.3 1.3 0.0 0.0   Cash and cash equivalent   6.5 113.9 6.5 6.5 93.0 6.5 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   44.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   24.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -99.8 -22.0 -47.0 -27.0 127.1 82.2 -18.5 -18.5   Net working capital %   -5.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   857 0 0 0 0 0 0 0   Added value / employee   65 53 4 24 124 -14 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   65 53 4 24 122 -14 0 0   EBIT / employee   27 10 -38 -20 80 -27 0 0   Net earnings / employee   10 -1 -38 -26 44 -28 0 0